295 related articles for article (PubMed ID: 16416115)
21. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcomes of patients with plasma cell leukemia in the era of novel therapies and hematopoietic stem cell transplantation strategies: a single-institution experience.
Lebovic D; Zhang L; Alsina M; Nishihori T; Shain KH; Sullivan D; Ochoa-Bayona JL; Kharfan-Dabaja MA; Baz R
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):507-11. PubMed ID: 21813352
[TBL] [Abstract][Full Text] [Related]
23. Primary plasma cell leukemia: a Surveillance, Epidemiology, and End Results database analysis between 1973 and 2004.
Ramsingh G; Mehan P; Luo J; Vij R; Morgensztern D
Cancer; 2009 Dec; 115(24):5734-9. PubMed ID: 19877113
[TBL] [Abstract][Full Text] [Related]
24. Plasma cell leukemia--a case report.
Badhe BA; Basu D; Toi PCh; Dutta TK; Ghotekar LH
Indian J Pathol Microbiol; 2003 Jul; 46(3):484-7. PubMed ID: 15025318
[TBL] [Abstract][Full Text] [Related]
25. [Plasma cell leukemia].
Egli F; Rhyner K
Schweiz Rundsch Med Prax; 1989 Jan; 78(3):29-34. PubMed ID: 2919252
[TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
An G; Qin X; Acharya C; Xu Y; Deng S; Shi L; Zang M; Sui W; Yi S; Li Z; Hao M; Feng X; Jin F; Zou D; Qi J; Zhao Y; Tai YT; Wang J; Qiu L
Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928
[TBL] [Abstract][Full Text] [Related]
27. VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia.
Ataergin S; Arpaci F; Kaya A; Cetin T; Gunhan O
Am J Hematol; 2006 Dec; 81(12):987-8. PubMed ID: 16888783
[No Abstract] [Full Text] [Related]
28. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
Gangadhar P; Ahmed Z; Pai MR; Sandhya I
Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
[TBL] [Abstract][Full Text] [Related]
29. [Plasma cell leukemia. Study of 10 cases].
López Guillermo A; Martí JM; Bladé J; Nomdedeu B; Montserrat E; Rozman C
Sangre (Barc); 1989 Feb; 34(1):28-31. PubMed ID: 2652343
[TBL] [Abstract][Full Text] [Related]
30. Frequent upregulation of MYC in plasma cell leukemia.
Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
[TBL] [Abstract][Full Text] [Related]
31. Plasma cell leukemia masquerading as ALL-L3--a case report.
Tripathy K; Gouda KP; Chakrabarty S; Das AK; Mohanty R
Indian J Pathol Microbiol; 2005 Apr; 48(2):221-3. PubMed ID: 16758674
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P
Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371
[TBL] [Abstract][Full Text] [Related]
34. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
35. [Acute plasma cell leukemia].
Monsalbe V; Domíngues C; Roa I; Busel D; González S
Rev Med Chil; 1989 Jan; 117(1):55-9. PubMed ID: 2641624
[TBL] [Abstract][Full Text] [Related]
36. [Secondary plasma cell leukemia. Report of 2 cases].
Sondes M; Choumous K; Moez E; Naourez A; Fatma BS; Faiza M; Taoufik S
Tunis Med; 2005 Jul; 83(7):433-6. PubMed ID: 16220704
[TBL] [Abstract][Full Text] [Related]
37. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
38. Plasma cell leukemia: Clinicopathologic, immunophenotypic and cytogenetic characteristics of 4 cases.
Alghasham N; Alnounou R; Alzahrani H; Alsharif F
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):71-7. PubMed ID: 25929729
[TBL] [Abstract][Full Text] [Related]
39. Plasma cell leukemia: a report on 15 patients.
Bernasconi C; Castelli G; Pagnucco G; Brusamolino E
Eur J Haematol Suppl; 1989; 51():76-83. PubMed ID: 2697596
[TBL] [Abstract][Full Text] [Related]
40. Molecular cytogenetic aberrations in 21 Chinese patients with plasma cell leukemia.
Xu W; Li JY; Fan L; Chen LJ; Qiu HR; Qiu HX; Lu H
Int J Lab Hematol; 2009 Jun; 31(3):338-43. PubMed ID: 18284415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]